Autoimmunity to ubiquitously expressed macromolecular
nucleic acid-
protein complexes such as the
nucleosome or the spliceosome is a characteristic feature of systemic
autoimmune diseases. Disease-specificity and/or association with clinical features of some of these autoimmune responses suggest pathogenic involvement which, however, has been proven in only a few cases so far. Although the mechanisms leading to autoimmunity against
nucleic acid-containing complexes are still far from being fully understood, there is increasing experimental evidence that the
nucleic acid component may act as a co-stimulator or adjuvans via activation of
nucleic acid-binding receptor systems such as
Toll-like receptors in antigen-presenting cells. Dysregulated apoptosis and inappropriate stimulation of
nucleic acid-sensing receptors may lead to loss of tolerance against the
protein components of such complexes, activation of autoreactive T cells and formation of
autoantibodies. This has been demonstrated to occur in
systemic lupus erythematosus and seems to represent a general mechanism that may be crucial for the development of systemic
autoimmune diseases. This review provides a comprehensive overview of the most thoroughly-characterized
nucleic acid-associated
autoantigens, describing their structure and biological function, as well as the nature and pathogenic importance of the reactivities directed against them. Furthermore, recent advances in
immunotherapy such as
antigen-specific approaches targeted at
nucleic acid-binding
antigens are discussed.